BMJ

Adaptive deep brain stimulation for Parkinson's disease demonstrates reduced speech side effects compared to conventional stimulation in the acute setting

Correspondence to Professor Peter Brown, Nuffield Department of Clinical Neurosciences, University of Oxford, Level 6, West Wing, John Radcliffe Hospital, Oxford OX3 9DU, UK; peter.brown{at}ndcn.ox.ac ...
BMJ

Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer’s disease

4 MRC Cognition and Brain Sciences Unit and University of Cambridge Neurology Unit, Addenbrooke’s Hospital, Cambridge, UK Correspondence to: Professor J R Hodges, MRC Cognition and Brain Sciences Unit ...
BMJ

Long-term functional decline of spontaneous intracerebral haemorrhage survivors

Correspondence to Professor Didier Leys, Neurology, Stroke Unit, University of Lille, Lille 59000, Hauts-de-France, France; didier.leys{at}univ-lille.fr Objective To identify in patients who survived ...
BMJ

Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, Anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone

Dr Jean-Yves Delattre, Service de Neurologie, Hôpital de la Salpêtrière, 47 Boulevard de l'Hôpital, 75651 Paris Cedex 13, France OBJECTIVES To evaluate the effect of a combination of immunoglobulins ...
BMJ

Repetitive speech phenomena in Parkinson's disease

OBJECTIVES Repetitive speech phenomena are morphologically heterogeneous iterations of speech which have been described in several neurological disorders such as vascular dementia, progressive ...
BMJ

Progression and prognosis in pure autonomic failure (PAF): comparison with multiple system atrophy

1 Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan 2 Department of Health Science, Nagoya University Graduate School of Medicine 3 Department of Neurology, ...
BMJ

Progressive biparietal atrophy: an atypical presentation of Alzheimer's disease.

OBJECTIVES: To define the clinical, neuropsychological, and radiological features of bilateral parietal lobe atrophy. METHODS: Four patients underwent a comprehensive longitudinal neuropsychological ...
BMJ

DNA methylation profiling in central nervous system tumours

The classification and management of central nervous system (CNS) tumours have undergone substantial transformation over the past two decades, with the recognition of an expanding set of molecularly ...
BMJ

Epstein-Barr virus reactivation as a trigger in autoimmune GFAP astrocytopathy

Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy is a rare Central Nervous System (CNS) inflammatory disorder, first defined in 2016 and identified by GFAP-IgG in cerebrospinal fluid ...
BMJ

Steroids or immunoglobulin for CIDP first-line treatment: why not both?

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
BMJ

Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3

Objective To retrospectively investigate safety and efficacy of nusinersen in a large cohort of adult Italian patients with spinal muscular atrophy (SMA). Methods Inclusion criteria were: (1) clinical ...
BMJ

Interstitial laser anterior capsulotomy for obsessive–compulsive disorder: lesion size and tractography correlate with outcome

Correspondence to Professor Peter Warnke, Neurosurgery, University of Chicago Biological Sciences Division, Chicago, IL 60637, USA; pwarnke{at}surgery.bsd.uchicago.edu Background Anterior capsulotomy ...